focus -WSS

focus

author：Wikipedia 2025-10-01 18:44:15 - browse：75

Here is STAT’s biotech scorecard, our regular ledger of stock-moving biotech events, for the fourth quarter:

The Food and Drug Administration’s decision in June to grant conditional approval to a gene therapy for Duchenne muscular dystrophy was a watershed moment for the treatment of the neuromuscular disease, and a big win for its maker, Sarepta Therapeutics. Confirming the gene therapy’s benefit — and potentially broadening its use to include older boys — will be determined by a Phase 3 clinical trial that will read out later this quarter.

Pfizeris developing its own gene therapy for Duchenne in a fully enrolled Phase 3 study with final results expected in 2024. But before the verdict is revealed, Pfizer intends to conduct an interim analysis later this quarter. The most likely outcome of this early look will be a determination to continue the study to its completion. But surprises — including an early stop for overwhelming efficacy — can’t be ruled out.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： Woman gored by Bison at Yellowstone

WSS

Blood tests recalled over risk of missed heart attack diagnosis

Chemotherapy before breast cancer surgery might fuel metastasis

Federal judge rules Oregon’s tough new gun law is constitutional

Can CDC director Mandy Cohen drive consensus in Washington?

Can gargling with Listerine treat gonorrhea of the mouth?

Michigan AG announces felony charges against 'fake electors' in 2020 election plot

explore

focus

focus

Heart attack and stroke risk calculators need revising

Elon Musk says Twitter has 'negative cash flow' and 'heavy debt'

Moonlake's readout produced a cash windfall. Risks remain

Brain technologies pose threats that are all too real, experts warn

Hepatitis C has a cure — but many Americans still lack access to it

Mike Pence clashes with Tucker Carlson in Iowa

Jerome Adams on the need for new antivirals for Covid

RFK Jr. accused of antisemitic claims about COVID but insists he was misunderstood

Bright Health sells Medicare Advantage business to Molina

Black vets could get higher VA benefits if race not used in lung test

leisure time

RFK Jr. accused of antisemitic claims about COVID but insists he was misunderstood

Federal judge rules Oregon’s tough new gun law is constitutional

Mike Pence clashes with Tucker Carlson in Iowa

Care demand spikes challenge UnitedHealth’s provider arm

Congress: Eradicate hepatitis C and reduce the deficit

Congress: Eradicate hepatitis C and reduce the deficit

knowledge

hotspot

hotspot

hotspot